G-Protein Receptor Work Wins Nobel

Robert J. Lefkowitz and Brian K. Kobilka take home this year’s Nobel Prize for Chemistry for revealing how membrane receptors sense and respond to chemical signals.

Written byDan Cossins
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Courtesy of HHMI and StanfordRobert J. Lefkowitz of Duke University and Brian K. Kobilka of Stanford have won this year’s Nobel Prize for Chemistry for describing the structure and function of the receptors through which cells sense and respond to chemical signals. The findings, awarded the prize this morning (October 10) by the Nobel Assembly at the Karolinska Institute in Stockholm, have transformed scientists’ understanding of many physiological processes and continue to support advances in drug design.

“They have helped us to develop deeper insights in to the mechanisms of cell reactions and the molecular structures behind them—insights that help us to understand the beautiful complexity of the chemical world inside us,” Bassam Shakhashiri, president of the American Chemical Society, told The Scientist. “Their contributions are extremely useful. Every day thousands of chemists use the results of their research in developing new pharmaceuticals for use in society.”

Since the discovery of cells in the 17th century, scientists have understood that these building blocks of life are constantly exposed to myriad chemical signals, which are then recognized, interpreted, and translated into a cellular response. But until around 20 years ago, how cells did this was a mystery. Scientists had suspected that cell surface ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies